Dermaliq Therapeutics

PharmaceuticalsSeries AWilmington, USdermaliq.com

Latest round

Series A

Last raised

Jan 2022

Total raised

$15M

Investors

2

About Dermaliq Therapeutics

Founded in 2021 and based in Delaware, US, Dermaliq Therapeutics, Inc. is a spin-off from Novaliq GmbH that operates as a pharmaceutical company that develops skincare therapies for patients with skin disease. In January 2022, Frank Löscher was appointed as CEO and president of the company, and Dermaliq Therapeutics, Inc. The company develops the next generation of skincare therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The technology is called hyliQ™, is designed to allow cutaneous drug delivery with unmatched bioavailability. The technology enables the development of liquid drug products with cosmetic properties.

Who invested in Dermaliq Therapeutics

2 investors across 1 round

See all investors in Dermaliq Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 18, 2022

    Amount

    $15M

    Investors

    Locked

Questions about Dermaliq Therapeutics

Who invested in Dermaliq Therapeutics?

Dermaliq Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dermaliq Therapeutics raised?

Dermaliq Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Dermaliq Therapeutics last raise money?

Dermaliq Therapeutics's most recent round on record is a Series A, in Jan 2022.

What does Dermaliq Therapeutics do?

Founded in 2021 and based in Delaware, US, Dermaliq Therapeutics, Inc.

Where is Dermaliq Therapeutics headquartered?

Dermaliq Therapeutics is headquartered in Wilmington, US.

Which VCs invest in companies like Dermaliq Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Dermaliq Therapeutics's stage. Their profiles are linked below.

Raising like Dermaliq Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.